Assignee
LSI MEDIENCE CORP
JP·11 granted patents·11 pending applications·10 citations·filing 2013–2023
Top patents by PatentIndex Score
22 records- 0182US10677695B2Magnetic material for collecting magnetic particles and utilization thereofLSI MEDIENCE CORP·Filed 2014·Granted Jun 9, 2020·7 cites·6 claims
- 0276US11873514B2Method of screening for a substance that acts on a cell massLSI MEDIENCE CORP·Filed 2022·Granted Jan 16, 2024·0 cites·20 claims
- 0365US2020256773A1Magnetic material for collecting magnetic particles and utilization thereofLSI MEDIENCE CORP·Filed 2020·Application pending·0 cites
- 0463US11237157B2Reagent and method for assaying thrombin-antithrombin complexLSI MEDIENCE CORP·Filed 2020·Granted Feb 1, 2022·0 cites·3 claims
- 0562US11549100B2Three-dimensional culture of primary cancer cells using tumor tissueLSI MEDIENCE CORP·Filed 2018·Granted Jan 10, 2023·0 cites·12 claims
- 0659USD1094772STesting instrumentLSI MEDIENCE CORP·Filed 2023·Granted Sep 23, 2025·2 cites·1 claims
- 0754US10168325B2Non-specific reaction inhibitorLSI MEDIENCE CORP·Filed 2014·Granted Jan 1, 2019·0 cites·8 claims
- 0851US9910052B2Method of diagnosing and treating infectious disseminated intravascular coagulationLSI MEDIENCE CORP·Filed 2013·Granted Mar 6, 2018·1 cites·8 claims
- 0950US2018106793A1Reagent and method for assaying thrombin-antithrombin complexLSI MEDIENCE CORP·Filed 2016·Application pending·0 cites
- 1050US2023116567A1Method for analyzing nucleic acid drugsLSI MEDIENCE CORP·Filed 2021·Application pending·0 cites
- 1148US11422128B2Immunoassay employing sulfated polysaccharideLSI MEDIENCE CORP·Filed 2017·Granted Aug 23, 2022·0 cites·5 claims
- 1248US2015346217A1USE OF sCD14 OR ITS FRAGMENTS OR DERIVATIVES FOR RISK STRATIFICATION, DIAGNOSIS AND PROGNOSISLSI MEDIENCE CORP·Filed 2013·Application pending·0 cites
- 1347US2023266323A1Diagnosis method for bladder cancerLSI MEDIENCE CORP·Filed 2021·Application pending·0 cites
- 1444US11225683B2Photocoupling method using probe containing photoresponsive nucleic acidsLSI MEDIENCE CORP·Filed 2013·Granted Jan 18, 2022·0 cites·14 claims
- 1540US11378577B2Reagent and method for measuring thrombin-antithrombin complexLSI MEDIENCE CORP·Filed 2016·Granted Jul 5, 2022·0 cites·3 claims
- 1639US2021382080A1AnalyzerLSI MEDIENCE CORP·Filed 2019·Application pending·0 cites
- 1734US2021396631A1Specimen slide for genetic testingLSI MEDIENCE CORP·Filed 2019·Application pending·0 cites
- 1834US2021349117A1Cuvette discarding unitLSI MEDIENCE CORP·Filed 2019·Application pending·0 cites
- 1933US2021270854A1Liposome-containing liquid reagent for measuring blood coagulation abilityLSI MEDIENCE CORP·Filed 2019·Application pending·0 cites
- 2032US10557848B2Polymer microparticle for carrying physiologically active substance and method for preparing sameLSI MEDIENCE CORP·Filed 2015·Granted Feb 11, 2020·0 cites·9 claims
- 2132US2022196688A1Transport mechanism and analyzing deviceLSI MEDIENCE CORP·Filed 2020·Application pending·0 cites
- 2227US2019265257A1Measurement reagent for cross-linked fibrin degradation product, and measurement methodLSI MEDIENCE CORP·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →